COMMENT UNDERNEATH ARCHIVE POST TO "Links to this post"
Comment moderation

Friday, September 18, 2009

Apraxia Study Unveils Possible Subset of Children with Previously Unrecognized Syndrome (SAAM)

A recently published study identifies a group of children with a syndrome of allergy, apraxia, and malabsorption (SAAM). When given a nutritional intervention containing a combination of omega-3 and vitamin E these children showed dramatic improvements in speech, communication, behavior, and motor skills.

Lake Forest, IL, September 17, 2009 --(PR.com)-- According to SpeechNutrients, the results of a recently published research study documents a previously unclassified group of children with a syndrome of allergy, apraxia, and malabsoption (SAAM) who respond to nutritional intervention. The study, published in the July-Aug 2009 edition of the journal of Alternative Therapies in Health and Medicine1, collected data on 187 children with verbal apraxia (VA). After supplementing with an omega-3 and vitamin E combination, 97% of the children showed dramatic improvements in speech, behavior, sensory issues, imitation, coordination, and eye contact.

Apraxia is a neurological disorder characterized by the inability to perform purposeful motor movements, despite having the desire and physical ability to perform the movements. Verbal apraxia affects the ability to produce normal sounds needed for speech while limb (motor) apraxia involves the programming of a hand, leg, or whole body movement. Limb apraxia often occurs with verbal apraxia.

The children in the study shared a commonality of male predominance, autism, sensory issues, low muscle tone, coordination challenges, food allergy, and gut issues. Due to allergies and malabsorption, these children may experience excess inflammation and oxidative stress that may be reduced through supplementation with a combination of omega-3 and vitamin E. Although the exact mechanisms contributing to the benefits remain to be determined, the majority of children experienced a reduction in the symptoms of apraxia. According to the study, “Use of high-dose PUFA and vitamin E in children with a history of VA appeared to lead to rapid clinical improvement of many symptoms of this neurological condition in a large cohort.” (Morris, Agin, p.39)

The SpeechNutrients division of NourishLife has produced an omega-3 and vitamin E nutritional formulation based on the Therapeutic Treatment of Apraxia patent licensed to NourishLife by Children’s Hospital & Research Center Oakland (CHRCO). Thousands of families have tried this formulation currently available as NourishLife speak, and hundreds have reported the same improvements experienced by children in the study.

Mark Nottoli, founder of NourishLife states, “The cases of verbal apraxia and autism are on the rise at an alarming rate. Even though autism is a relatively known condition by the general population, apraxia is not. We now know that over 500,000 children have been diagnosed with autism, and of those, an estimated half may have apraxia. This study is consequential in that not only does it highlight a previously unrecognized combination of apraxia, allergy, and malabsorption, but it suggests help in the form of nutritional intervention.”

Nottoli continues, “Our nutritional supplement NourishLife speak contains the combination of omega-3 and vitamin E nutrients shown to be effective. We are excited that the availability of speak will enable more families to try this nutritional formulation to see if speak is helpful for their child. Already, the results have been stunning. Parents are reporting first words spoken, more complex sentences, easier word recall, and even singing in addition to improved motor planning and movements.”

To learn more about the study and the nutrients used therein, please visit http://www.speechnutrients.com/LP/study.aspx. NourishLife speak™ is available at www.SpeechNutrients.com or by calling 800-471-0358.

1Morris, Claudia R, and Agin, Marilyn C. Syndrome of Allergy, Apraxia, and Malabsorption: Characterization of a Neurodevelopmental Phenotype that Responds to Omega 3 and Vitamin E Supplementation. Alternative Therapies in Health and Medicine 2009; Vol. 15, No. 4: 32-41.

About NourishLife:
NourishLife (www.NourishLifeppp.com) intends to contribute to a major improvement in health and wellness by addressing nutritional deficiencies. Founded by nutrition industry veterans, the firm includes expert scientists and nutritionists passionate about health.

The firm was awarded an exclusive license to a patented nutritional formulation designed to support normal speech development. Preliminary evidence shows promise with reports of benefits that include improved speech, imitation, coordination, eye contact, behavior and sensory issues. NourishLife formed a partnership with Croda, the makers of Lorenzo’s Oil, for the pharmaceutical grade omega 3 used in their speak™ product. More information can be found at www.SpeechNutrients.com.

NourishLife is a privately held business located outside of Chicago.

Press Contact:
Kara Bolton, NourishLife LLC, 250 E. Deerpath Road, Lake Forest, IL 60045 USA Tel: 847-582-1316
Email: kara@SpeechNutients.com

###
Contact Information
NourishLife
Kara Bolton
847-582-1316
kara@nlppp.com
www.speechnutrients.com
Apraxia Study Unveils Possible Subset of Children with Previously Unrecognized Syndrome (SAAM)SocialTwist Tell-a-Friend

No comments:

Post a Comment

There was an error in this gadget